z-logo
open-access-imgOpen Access
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
Author(s) -
Elizabeth Smith,
Herbert Pang,
Constance Cirrincione,
Stewart B. Fleishman,
Electra D. Paskett,
Tim A. Ahles,
Linda R. Bressler,
Camilo E. Fadul,
Chetaye Knox,
Nguyet LeLindqwister,
Paul Gilman,
Charles L. Shapiro,
for the Alliance for Clinical Trials in Oncology
Publication year - 2013
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2013.2813
Subject(s) - duloxetine , medicine , chemotherapy induced peripheral neuropathy , placebo , duloxetine hydrochloride , peripheral neuropathy , adverse effect , brief pain inventory , neuropathic pain , common terminology criteria for adverse events , randomized controlled trial , oxaliplatin , pregabalin , chemotherapy , anesthesia , physical therapy , chronic pain , cancer , diabetes mellitus , alternative medicine , colorectal cancer , pathology , endocrinology
There are no known effective treatments for painful chemotherapy-induced peripheral neuropathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom